New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2014
07:37 EDTSUPNSupernus receives FDA fast track designation for SPN-810
Supernus Pharmaceuticals announced that the United States Food and Drug Administration has granted fast track designation for SPN-810 for the treatment of impulsive aggression in attention deficit hyperactivity disorder. This product candidate is expected to enter Phase III testing, with patient dosing commencing during 2015.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 21, 2014
16:15 EDTSUPNSupernus sues Zydus for infringement of Trokendi patents
Subscribe for More Information
November 12, 2014
09:21 EDTSUPNOn The Fly: Pre-market Movers
Subscribe for More Information
November 11, 2014
16:38 EDTSUPNSupernus expects to be profitable in 2015
Subscribe for More Information
16:34 EDTSUPNSupernus updates progress of product candidates
Subscribe for More Information
16:33 EDTSUPNSupernus raises FY14 revenue view to $115M-$118M from $105M
FY14 consensus $104.44M. The company is reducing its cash burn guidance for the year from $5M-10M to approximately $5M, and raising its guidance for year end cash and marketable securities to approximately $85M. The company anticipates achieving cash flow break even by year end and being profitable in 2015.
16:32 EDTSUPNSupernus reports Q3 EPS 39c, consensus 36c
Reports Q3 revenue $52.5M, consensus $43.08M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use